✦ LIBER ✦

Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?

✍ Scribed by Doris Wagner; Astrid Fahrleitner-Pammer

Publisher: Springer Vienna
Year: 2010
Tongue: German
Weight: 105 KB
Volume: 160
Category: Article
ISSN: 0043-5341
DOI: 10.1007/s10354-010-0818-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of osteoprotegerin (OPG) recept

The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology – a review

✍ Daniela-Eugenia Malliga; Doris Wagner; Astrid Fahrleitner-Pammer 📂 Article 📅 2011 🏛 Springer Vienna 🌐 German ⚖ 100 KB

Plasma levels of receptor activator of n

Plasma levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in patients with neuroblastoma

✍ Donatella Granchi; Alberto Garaventa; Ilaria Amato; Paolo Paolucci; Nicola Baldi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB

## Abstract Earlier reports showed that the balance between receptor activator of nuclear factor‐κB ligand (RANKL) and its decoy‐receptor osteoprotegerin (OPG) plays an important role in the pathogenesis of metastatic osteolysis induced by neuroblastoma cells. In this study, we investigated whether

Soluble receptor activator of nuclear fa

Soluble receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation

✍ Chun-Hsiung Chen; Hung-An Chen; Hsien-Tzung Liao; Chin-Hsiu Liu; Chang-Youh Tsai 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 160 KB

Serum osteoprotegerin and receptor activ

Serum osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?

✍ K. Kananen; L. Volin; K. Laitinen; T. Ruutu; M. J. Välimäki 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 136 KB

Elevated serum receptor activator of NFκ

Elevated serum receptor activator of NFκB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis

✍ Pradip Kumar Sarma; Ramnath Misra; Amita Aggarwal 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 137 KB

Receptor Activator of Nuclear Factor Kap

Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Modulates the Expression of Genes Involved in Apoptosis and Cell Cycle in Human Osteoclasts

✍ Erika Rimondi; Marina Zweyer; Enrico Ricci; Roberto Fadda; Paola Secchiero 📂 Article 📅 2007 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 307 KB 👁 2 views

## Abstract It has been clearly established that receptor activator of nuclear factor kappa B ligand (RANKL) is a key cytokine involved in the differentiation of osteoclastic precursors of the monocytic/macrophagic lineage. However, relatively little information is available on the ability of RANKL